Synta (SNTA) Completes Additional 1.05M Common Sale

Synta Pharmaceuticals Corp. (Nasdaq: SNTA) has completed the sale of 1,050,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriters of its previously announced public offering. After underwriting discounts and commissions and estimated offering expenses payable by Synta, aggr

---

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In

• Euroseas (ESEA) commences 13.9M rights offering
• Dow Chemical (DOW) Wins $2.16B in K-Dow Arbitration
• LDK Solar (LDK) Issues Statement on DoC Anti-Dumping Duty; Will Not Change Strategy

Create E-mail Alert Related Categories

Corporate News, Equity Offerings

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter